about
Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosisReproductive performance of women with müllerian anomaliesCoordinated regulation of HOX gene expression in myometrium and uterine leiomyoma.Intra-uterine adhesions and fertility outcome: how to optimize success?Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007.Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system.Evidence-based diagnosis and management of tubal factor infertility.Luteal phase defect: myth or reality.Inhibition of chemokines prevents intraperitoneal adhesions in mice.Basic aspects of implantation.Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis.Poor responders: does the protocol make a difference?New advances in the understanding of endometriosis related infertility.Uterine chemokines in reproductive physiology and pathology.Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata.The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and survival of human endometrial implants in the nude mice endometriosis model.Diagnostic role of inhibin B in resistant ovary syndrome associated with secondary amenorrhea.Effect of estradiol on oocyte development.Medical management of endometriosis-associated pain.Failed fertilization: is it predictable?Immune testing in fertility practice: truth or deception?Endometriosis: interaction of immune and endocrine systems.Apoptosis and the pathogenesis of endometriosis.Immunology and endometriosis.Assessment of ovarian reserve.Endometriosis and inflammation in infertility.Fibroids and in-vitro fertilization: which comes first?Natural killer cells and reproductive failure.Statins inhibit monocyte chemotactic protein 1 expression in endometriosis.Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery.Anatomic factors in recurrent pregnancy loss.Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors.Options for medical treatment of myomas.Myomas and assisted reproductive technologies: when and how to act?Endometrial cancer and fertility.The role of endometrium in endometriosis.Role of gonadotropin-releasing hormone antagonists in poor responders.Endometriosis and infertility: epidemiology and evidence-based treatments.Fragile X and reproduction.Advances in treatment options of endometriosis.
P50
Q24244595-17983A1C-7AA0-49A2-89DA-C210F1A4C8E3Q28301834-7B2DD499-14F6-49DD-AE6F-0E8C543F26F2Q30868227-6BD498D9-74A4-4AC5-AC05-0B4F724AD6EDQ33284367-4CC6AB61-5CF8-4974-93FF-FE7DEFB7528AQ33331152-6B60255E-85D4-4885-910A-098E1F332760Q34223964-C46CC232-093F-442D-826F-04AEF80EAE72Q34318997-5AE4548C-2471-4A2B-B98A-C6A09F4E77B0Q34369121-4D00802C-F81C-4C26-B9CC-D50997FE7608Q34432665-FF321B21-099A-4D22-AFA1-E6C4722C1B7CQ34585834-F5B56B78-56A8-40AE-85F4-1EC9195233DAQ34597278-B86E434D-FE66-4C62-A08D-F8FE142F8A0BQ34658172-DC60E7A9-9BE2-48A5-8119-02007BB7B63BQ34683517-C516912F-798A-4BA4-893C-983A93CE2841Q34690685-93BFFD11-1DF5-4580-8BD9-568A3B6979CDQ34719524-E6052E60-9078-48F5-9F1A-3D35E3E24AA7Q34727292-6B324E7E-F2BB-41E0-84D4-F748111315D1Q35023583-53937F1E-3A34-4EFD-8A08-7FD9E7D0A977Q35023817-D22D3F79-0801-49A2-BBDD-558C62F9466FQ35108932-2A1FEA59-DBFC-4D55-AE64-F0A8631ABF0EQ35176545-8845730E-9974-4E08-9875-380ACD8DC424Q35176552-3F8B5F44-5DED-427E-8923-6FEF04AB93FFQ35199230-5C760BB8-7305-4AA8-9B3C-CA586AC38690Q35199241-F997B729-B2C1-4B8B-994B-214FDDE0DD79Q35542247-68464B67-69DF-4D76-8F12-9423A2E8D2E1Q35765333-27DDD397-D326-44BB-BE1E-CBF6B2B65BA4Q36054365-AAFAF909-9353-4DE4-8A78-DEE5EA9027A1Q36115915-913AB136-F034-4C1E-9692-9D9BB90ED063Q36115927-EB322A19-032F-4D39-AC88-08B6BA18B4A3Q36225986-825ABA6A-7DB9-44A4-8854-7616C70C81DAQ36360780-E9EBCB24-27D1-4D3C-856C-F4D1619AA33EQ36371281-72D8043A-D57F-4889-8D16-084F1DCC2674Q36407934-B5AC449E-E307-4020-BCE0-FC22027B7C10Q36407951-AE2A5D09-A3AB-4F11-B0A6-376AF169A11DQ36407957-49D0759A-BA3A-4D71-AF49-597E0E57171BQ36493062-19A8F859-F2BF-49CC-8187-6634F0FA540EQ36600512-4B9F3323-8C56-4050-9936-4D64528D5684Q36656825-BFA03332-4907-4A50-91E8-ACA6514EB4B0Q37149763-EBB0D4DD-D536-4266-8913-14D74F555EAAQ37156343-6F47145E-B3C1-4BB6-A9EC-6C6D68427146Q37302667-79B28CDD-B517-47C1-AF9B-A320E5E25BED
P50
name
Aydin Arici
@en
Aydin Arici
@nl
type
label
Aydin Arici
@en
Aydin Arici
@nl
prefLabel
Aydin Arici
@en
Aydin Arici
@nl